Abstract
This year's bumpy budget-making journey ended in a relatively smooth landing late last month with a record raise for U.S. biomedical science and increases for many other basic research budgets. While the final numbers are still being tallied, analysts expect overall government R&D spending to rise by more than 6%, to some $100 billion, in the 2002 fiscal year that began 1 October. Some of the money has strings attached, however, as lawmakers ordered up an unprecedented number of earmarks.

This publication has 0 references indexed in Scilit: